# bib

id: cord-304211-5uzqqbr4
author: Tammaro, A.
title: Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome
date: 2020-04-24
extension: .txt
mime: text/plain
words: 455
sentence: 17
flesch: 43
cache: cache/cord-304211-5uzqqbr4.txt
txt: txt/cord-304211-5uzqqbr4.txt
summary:
  key: cord-304211-5uzqqbr4 authors: Tammaro, A.; Adebanjo, G.A.R.; Parisella, F.R.; Pezzuto, A.; Rello, J. title: Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome date: 2020-04-24 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16530 sha: doc_id: 304211 cord_uid: 5uzqqbr4 In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causing Coronavirus disease 2019 (COVID‐19) emerged in Wuhan, Hubei Province, China. We could speculate that they could be caused by either Human herpes virus 1 (HHV-1), Human herpes virus 2 (HHV-2) or Varicella Zoster Virus (VZV, To date, there is only one report that investigates the prevalence and nature of dermatological manifestations associated to the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 6 .


id: cord-327036-0260rrdx
author: Dominguez‐Santas, M.
date: 2020-05-26
extension: .txt
mime: text/plain
words: 413
sentence: 18
flesch: 42
cache: cache/cord-327036-0260rrdx.txt
txt: txt/cord-327036-0260rrdx.txt
title:
  Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19)

summary:
  Doctors dealing with CSVV in undiagnosed patients during this pandemic may take into consideration testing for SARS-CoV-2. There are numerous reports of viral-induced vasculitis, either associated with cryoglobulin presence (as in HCV infected patients) 4 , or unrelated to them (as in individuals with influenza-vaccine-induced vasculitis) 5 .


id: cord-260218-add4i1c9
author: Bosch‐Amate, X
title: Retiform purpura as a dermatological sign of covid‐19 coagulopathy
date: 2020-06-03
extension: .txt
mime: text/plain
words: 449
sentence: 21
flesch: 34
cache: cache/cord-260218-add4i1c9.txt
txt: txt/cord-260218-add4i1c9.txt
summary:
  Recalcati(1) asserted that 20.4% of infected patients developed cutaneous manifestations and Galván‐Casas et al(2) have recently proposed 5 clinical patterns (pseudo‐chilblain, vesicular, urticarial, maculopapular and livedo/necrosis). From now on, we will have to include COVID-19 infection in the differential diagnosis of retiform purpura.


id: cord-282750-d9sb7o63
author: Benhadou, F.
title: Improvement of SARS‐CoV2 symptoms following Guselkumab injection in a psoriatic patient
date: 2020-05-07
extension: .txt
mime: text/plain
words: 552
sentence: 12
flesch: 17
cache: cache/cord-282750-d9sb7o63.txt
txt: txt/cord-282750-d9sb7o63.txt
summary:
  Interestingly, the cytokine profile associated with SARS-CoV2 infection severity is characterised by increased levels of tumor necrosis factor , IL-1, IL-2, IL-6, IL-7, granulocyte colony stimulating factor, interferon(IFN)-γ inducible protein 10, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1-α among others 4 By targeting the IL-23p19 subunit, Guselkumab does not increase the risk for viral, bacterial or fungal infections among psoriasis patients 5 . In the eye of the COVID-19 cytokine storm COVID-19: consider cytokine storm syndromes and immunosuppression Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis:


id: cord-314422-u2elzgl8
author: Bothra, Atul
title: Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic
date: 2020-06-03
extension: .txt
mime: text/plain
words: 494
sentence: 22
flesch: 38
cache: cache/cord-314422-u2elzgl8.txt
txt: txt/cord-314422-u2elzgl8.txt
summary:
  key: cord-314422-u2elzgl8 authors: Bothra, Atul; Das, Seujee; Singh, Mehak; Pawar, Manoj; Maheswari, Anshu title: Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic date: 2020-06-03 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16692 sha: doc_id: 314422 cord_uid: u2elzgl8 The COVID‐19 pandemic forged theexponential use of masks of various kinds, not just by health workers but also by general population as a personal protective equipment (PPE). All rights reserved trapping of sweat, use of disinfectant to reuse masks, application of dyes to colour homemade masks are frequent causes of dermatitis using ear loop face masks.


id: cord-258581-46p0k9lc
author: Bodak, Nathalie
title: COVID‐19 Lockdown induced acral dermatosis in children
date: 2020-06-28
extension: .txt
mime: text/plain
words: 557
sentence: 22
flesch: 45
cache: cache/cord-258581-46p0k9lc.txt
txt: txt/cord-258581-46p0k9lc.txt
summary:
  key: cord-258581-46p0k9lc authors: Bodak, Nathalie; Chiaverini, Christine; Barbarot, Sebastien title: COVID‐19 Lockdown induced acral dermatosis in children date: 2020-06-28 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16797 sha: doc_id: 258581 cord_uid: 46p0k9lc Recently, several case series of cutaneous acral manifestations in patients with suspected or confirmed coronavirus disease 2019 (COVID‐19) have been reported. Although a larger case series would strengthen our hypothesis, we suggest that the change of daily habits in young children during the lockdown period may have increased the frequency of acral frictional dermatoses that are not directly due to the virus but rather to prolonged sessions spent playing on the floor.


id: cord-341999-nosdj7b2
author: Conti, A.
title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs
date: 2020-05-07
extension: .txt
mime: text/plain
words: 604
sentence: 19
flesch: 32
cache: cache/cord-341999-nosdj7b2.txt
txt: txt/cord-341999-nosdj7b2.txt
summary:
  However, few reports are available on the course of COVID-19 infection in psoriatic patients treated with biological drugs (2) . key: cord-341999-nosdj7b2 authors: Conti, A.; Lasagni, C.; Bigi, L.; Pellacani, G. title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date: 2020-05-07 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16587 sha: doc_id: 341999 cord_uid: nosdj7b2 Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1).


id: cord-341118-h5t87vf8
author: Torres‐Navarro, Ignacio
date: 2020-05-26
extension: .txt
mime: text/plain
words: 631
sentence: 39
flesch: 48
cache: cache/cord-341118-h5t87vf8.txt
txt: txt/cord-341118-h5t87vf8.txt
title:
  A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue

summary:
  All rights reserved Cutaneous manifestations in COVID-19: a first perspective Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern Recent advances in the understanding of severe cutaneous adverse reactions Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection Acknowledgments: The patient in this manuscript has given written informed consent to the publication of her case details. All rights reserved Dear editor, We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID-19 patients.


id: cord-295551-ujnks5ox
author: Estébanez, Andrea
title: Cutaneous manifestations in COVID‐19: a new contribution
date: 2020-04-15
extension: .txt
mime: text/plain
words: 645
sentence: 31
flesch: 53
cache: cache/cord-295551-ujnks5ox.txt
txt: txt/cord-295551-ujnks5ox.txt
summary:
  key: cord-295551-ujnks5ox authors: Estébanez, Andrea; Pérez‐Santiago, Leticia; Silva, Esmeralda; Guillen‐Climent, Santiago; García‐Vázquez, Alejandro; Ramón, M. Dolores title: Cutaneous manifestations in COVID‐19: a new contribution date: 2020-04-15 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16474 sha: doc_id: 295551 cord_uid: ujnks5ox We have read with great interest Dr Recalcati’s review about skin manifestations in COVID‐19 as it is the first report on this subject(1). We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject 1 .


id: cord-326737-b6gs9z4h
author: Balestri, R.
title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections
date: 2020-07-27
extension: .txt
mime: text/plain
words: 706
sentence: 27
flesch: 41
cache: cache/cord-326737-b6gs9z4h.txt
txt: txt/cord-326737-b6gs9z4h.txt
summary:
  Concerning the urethritis and cervicitis, symptoms were reported by 10 of 11 patients, while the last patient was asymptomatic but underwent testing because her partner had recently received a diagnosis of C. trachomatis infections. Therefore, we suggest that visits of STI patients should not be cancelled, making use of teledermatology where possible and visiting any doubtful cases.


id: cord-282653-9n5sjn23
author: Rodríguez‐Jiménez, Pedro
date: 2020-05-09
extension: .txt
mime: text/plain
words: 687
sentence: 32
flesch: 48
cache: cache/cord-282653-9n5sjn23.txt
txt: txt/cord-282653-9n5sjn23.txt
title:
  Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection”: Urticaria‐like lesions in COVID‐19 patients are not really urticaria. A case with clinicopathologic correlation

summary:
  A case with clinicopathologic correlation date: 2020-05-09 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16618 sha: doc_id: 282653 cord_uid: 9n5sjn23 We have read with great attention the article by Van Damme et al. considering urticarial lesions as a coronavirus disease 2019 (COVID‐19) associated skin manifestation(1). All rights reserved Dear Editor, We have read with great attention the article by Van Damme et al. considering urticarial lesions as a coronavirus disease 2019 (COVID-19) associated skin manifestation 1 .


id: cord-346017-wforwxes
author: Kasperkiewicz, M.
date: 2020-04-25
extension: .txt
mime: text/plain
words: 649
sentence: 27
flesch: 26
cache: cache/cord-346017-wforwxes.txt
txt: txt/cord-346017-wforwxes.txt
title:
  Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic

summary:
  Since immunosuppressive therapy can generally inhibit antiviral immunity, AIBD patients undergoing immunomodulatory treatment, especially elderly patients with co-morbidities, may be at higher risk of worse outcomes should they develop COVID-19. key: cord-346017-wforwxes authors: Kasperkiewicz, M.; Schmidt, E.; Fairley, J.A.; Joly, P.; Payne, A.S.; Yale, M.L.; Zillikens, D.; Woodley, D.T. title: Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic date: 2020-04-25 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16525 sha: doc_id: 346017 cord_uid: wforwxes Autoimmune bullous diseases (AIBDs) are potentially life‐threatening disorders comprising intra‐epidermal/epithelial (pemphigus) and sub‐epidermal/epithelial blistering diseases (pemphigoid and dermatitis herpetiformis).


id: cord-342254-vdovpfu1
author: Mugheddu, C.
date: 2020-06-04
extension: .txt
mime: text/plain
words: 768
sentence: 28
flesch: 32
cache: cache/cord-342254-vdovpfu1.txt
txt: txt/cord-342254-vdovpfu1.txt
title:
  CID‐19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management

summary:
  Psoriasis treatment relies on immunosuppression, and although most experts agree that the benefit-to risk-ratio is in favor of maintaining selective biologic therapies, and small molecules such as apremilast, they recommend dismission if severe COVID-19 symptoms occur. First of all, the information of apremilast safety, not interfering with the infection, as the drug was not interrupted during the whole course of the infection.


id: cord-253552-qreg4emx
author: Bouaziz, JD
title: Vascular skin symptoms in COVID‐19: a french observational study
date: 2020-04-27
extension: .txt
mime: text/plain
words: 762
sentence: 32
flesch: 34
cache: cache/cord-253552-qreg4emx.txt
txt: txt/cord-253552-qreg4emx.txt
summary:
  Importantly, French dermatologists belonging to the SNDV reported numerous chilblain lesions in persons in close contact with COVID-19+ patients without COVID-19 PCR confirmation and without general symptoms of COVID-19 infections which raises 3 hypotheses: these chilblain lesions may: i/ be due to another confounding factor than COVID-19, ii/ be due to a post viral immunological reaction in asymptomatic forms of COVID-19, iii/ represent a skin presentation of COVID-19 infection in a subgroup of patients with peculiar immune anti-viral response. Usual clinical manifestations of COVID-19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome and death (1).


id: cord-303514-2ljmkabk
author: Recalcati, S.
title: Acral cutaneous lesions in the time of COVID‐19
date: 2020-05-27
extension: .txt
mime: text/plain
words: 783
sentence: 33
flesch: 40
cache: cache/cord-303514-2ljmkabk.txt
txt: txt/cord-303514-2ljmkabk.txt
summary:
  key: cord-303514-2ljmkabk authors: Recalcati, S.; Barbagallo, T.; Frasin, L.A.; Prestinari, F.; Cogliardi, A.; Provero, M.C.; Dainese, E.; Vanzati, A.; Fantini, F. title: Acral cutaneous lesions in the time of COVID‐19 date: 2020-05-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16533 sha: doc_id: 303514 cord_uid: 2ljmkabk Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. The temporal relationship with the COVID-19 pandemia, the rapid outbreak and clustering of unusual skin lesions, the occurrence of familial cases in a situation of home restriction and the multiple reporting of similar cases from other affected areas in parallel with pandemic diffusion strongly support this hypothesis.


id: cord-266475-t04pukea
author: Balestri, R.
title: Late onset of acral necrosis after SARS‐CoV‐2 infection resolution
date: 2020-05-26
extension: .txt
mime: text/plain
words: 865
sentence: 31
flesch: 36
cache: cache/cord-266475-t04pukea.txt
txt: txt/cord-266475-t04pukea.txt
summary:
  Authors have therefore suggested some pathogenetic mechanisms such as a delayed immune‐mediated reaction to the virus in genetically‐predisposed patients(1) or an early IFN‐I response in young patients, muting early viral replication but also inducing microangiopathic changes. Authors have therefore suggested some pathogenetic mechanisms such as a delayed immunemediated reaction to the virus in genetically-predisposed patients 1 or an early IFN-I response in young patients, muting early viral replication but also inducing microangiopathic changes.


id: cord-252123-z8c14q5d
author: Negrini, S.
title: An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient
date: 2020-06-19
extension: .txt
mime: text/plain
words: 827
sentence: 38
flesch: 24
cache: cache/cord-252123-z8c14q5d.txt
txt: txt/cord-252123-z8c14q5d.txt
summary:
  key: cord-252123-z8c14q5d authors: Negrini, S.; Guadagno, A.; Greco, M.; Parodi, A.; Burlando, M. title: An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient date: 2020-06-19 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16760 sha: doc_id: 252123 cord_uid: z8c14q5d A novel Coronavirus strain, named “Severe Acute Respiratory Syndrome Coronavirus 2” (SARS‐CoV‐2) was recently identified as the etiological agent of the COronaVIrus Disease 2019 (COVID‐19). The case described is an unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient.


id: cord-339195-aq3hb68r
author: Falkenhain‐López, D.
title: COVID‐19‐related acute genital ulcers
date: 2020-06-26
extension: .txt
mime: text/plain
words: 856
sentence: 44
flesch: 42
cache: cache/cord-339195-aq3hb68r.txt
txt: txt/cord-339195-aq3hb68r.txt
summary:
  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Cutaneous manifestations in COVID-19: a first perspective Pityriasis rosea as a cutaneous manifestation of COVID-19 infection A dermatologic manifestation of COVID-19: transient livedo reticularis Ulcus vulvae acutum Lipsch€ utz: a systematic literature review and a diagnostic and therapeutic algorithm Lipschutz ulcers: evaluation and management of acute genital ulcers in women Lipsch€ utz's acute vulvar ulcer: a systematic review Non-sexually related acute genital ulcers in 13 pubertal girls: a clinical and microbiological study Oral vesiculobullous lesions associated with SARS-CoV-2 infection The patients in this manuscript have given written informed consent to the publication of their case details. She had never presented genital ulcers before.


id: cord-283716-tleh9323
author: Amatore, F.
title: SARS‐CoV‐2 infection presenting as a febrile rash
date: 2020-05-27
extension: .txt
mime: text/plain
words: 830
sentence: 34
flesch: 39
cache: cache/cord-283716-tleh9323.txt
txt: txt/cord-283716-tleh9323.txt
summary:
  Indeed, the annular, polycyclic and circinate appearance of the skin lesions differed from classic paraviral rashes in adults, as did the papules on the palms. For instance, some patients with Covid-19 associated cutaneous manifestation have been reported, but there is a lack of iconographic and histological documentation.


id: cord-323334-ie7iklr4
author: Tartari, F
title: Changes in emergency service access after spread of COVID19 across Italy
date: 2020-04-27
extension: .txt
mime: text/plain
words: 897
sentence: 33
flesch: 48
cache: cache/cord-323334-ie7iklr4.txt
txt: txt/cord-323334-ie7iklr4.txt
summary:
  Dermatologic emergencies: descriptive analysis of 861 patients in a tertiary care teaching hospital Cutaneous conditions leading to dermatology consultations in the emergency department Primary care and pattern of skin diseases in a Mediterranean island Evaluation of emergency dermatological consultations in a tertiary care centre in North India Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances Dermatological consultations in an observation unit of an emergency department in Italy key: cord-323334-ie7iklr4 authors: Tartari, F; Guglielmo, A; Fuligni, F; Pileri, A title: Changes in emergency service access after spread of COVID19 across Italy date: 2020-04-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16553 sha: doc_id: 323334 cord_uid: ie7iklr4 The Italian National Health System is currently living through some catastrophic days, owing to the rapid spread of COVID‐19 across the country.


id: cord-309507-oe4i6v5x
author: Sacchelli, L.
date: 2020-06-03
extension: .txt
mime: text/plain
words: 891
sentence: 41
flesch: 49
cache: cache/cord-309507-oe4i6v5x.txt
txt: txt/cord-309507-oe4i6v5x.txt
title:
  Sexually Transmitted Infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice

summary:
  Moreover, the profile of patients and the type of medical provisions required changed. Patients characteristics and medical provisions before and after the lockdown were consistent with the literature 3,6,7 .


id: cord-344273-uztk6pc0
author: Tejera‐Vaquerizo, Antonio
title: Estimated effect of COVID‐19 lockdown on melanoma thickness and prognosis: a rate of growth model
date: 2020-05-02
extension: .txt
mime: text/plain
words: 875
sentence: 33
flesch: 50
cache: cache/cord-344273-uztk6pc0.txt
txt: txt/cord-344273-uztk6pc0.txt
summary:
  Challenges for Global Health Governance The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: A prospective study An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed Growth rate as a prognostic factor in localized invasive cutaneous melanoma Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma. To estimate this impact, we built a model based on melanoma rate of growth (ROG).


id: cord-301483-dsaltzdd
author: Hashizume, H.
title: Eosinophilic granulomatosis with polyangiitis mimicking COVID‐19: a case report
date: 2020-06-04
extension: .txt
mime: text/plain
words: 898
sentence: 43
flesch: 43
cache: cache/cord-301483-dsaltzdd.txt
txt: txt/cord-301483-dsaltzdd.txt
summary:
  All rights reserved computed tomogram revealed bilateral interstitial shadows (Fig. 1) , like those frequently seen in COVID-19 cases, so a pulmonologist segregated him on suspicion of COVID-19. The patient's complete response to steroid therapy, which usually causes deterioration in COVID-19 cases, supports our diagnosis.


id: cord-270500-5pkx94zu
author: Duong, T.A.
title: Did Whatsapp(®) reveal a new cutaneous COVID‐19 manifestation?
date: 2020-05-19
extension: .txt
mime: text/plain
words: 890
sentence: 39
flesch: 41
cache: cache/cord-270500-5pkx94zu.txt
txt: txt/cord-270500-5pkx94zu.txt
summary:
  This clinical presentation was not reported among skin manifestations in inhospital cases series. [2] [3] [4] [5] On the Whatsapp â group, which included four hundred dermatologists, atypical skin eruptions or lesions of suspected or confirmed COVID-19 patients were posted.


id: cord-272321-znnipzym
author: Verheyden, M.
title: Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection
date: 2020-06-25
extension: .txt
mime: text/plain
words: 857
sentence: 60
flesch: 40
cache: cache/cord-272321-znnipzym.txt
txt: txt/cord-272321-znnipzym.txt
summary:
  Bibliography Cutaneous manifestations in COVID-19: a first perspective Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19 COVID-19 Presenting with Atypical Sweet's Syndrome A distinctive skin rash associated Symmetric cutaneous vasculitis in COVID-19 pneumonia Late onset of acral necrosis after SARS-CoV-2 infection resolution Vascular skin symptoms in COVID-19: a french observational study Antinuclear antibodies in infectious diseases Braun-Falco's Dermatologie, venerologie und Allergologie The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome FACT SHEET: COVID-19 disease (SARS-CoV-2 virus), Version 2


id: cord-281703-6xwcxe8l
author: Di Altobrando, Ambra
title: Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?
date: 2020-04-17
extension: .txt
mime: text/plain
words: 999
sentence: 32
flesch: 30
cache: cache/cord-281703-6xwcxe8l.txt
txt: txt/cord-281703-6xwcxe8l.txt
summary:
  Therefore, it will be crucial for our community to learn of more cases of autoimmune bullous disease patients under immunosuppressive treatment who have developed COVID-19, in order to better quantify the risk of infection under immunosuppressive therapy. But what about patients already in immunosuppressive therapy for these potentially life-threatening disorders?


id: cord-299143-vcfu79ij
author: McCoy, John
date: 2020-09-25
extension: .txt
mime: text/plain
words: 1007
sentence: 52
flesch: 47
cache: cache/cord-299143-vcfu79ij.txt
txt: txt/cord-299143-vcfu79ij.txt
title:
  Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients

summary:
  AR CAG repeat region was PCR-amplified and 300bp paired-end sequencing was performed using a MiSeq (Illumina, San Diego, California). Further, estimating 40% of hospitalized COVID-19 male patients are likely admitted to the ICU, 5 the Bayes' adjusted positive predictive value of the AR CAG score in predicting ICU admissions was 53.202% (95%CI: 39.646%-66.301%) and the negative predictive value was 71.938% (95%CI: 60.693%-80.974%).


id: cord-304946-fs02dxg5
author: Brochez, L.
title: Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic
date: 2020-08-12
extension: .txt
mime: text/plain
words: 1062
sentence: 39
flesch: 41
cache: cache/cord-304946-fs02dxg5.txt
txt: txt/cord-304946-fs02dxg5.txt
summary:
  Medical doctors were faced with prioritization of non-COVID19 medical problems in order to reduce potential exposures and to mobilize staff and resources for COVID-19 care. key: cord-304946-fs02dxg5 authors: Brochez, L.; Baurain, J.F.; Del Marmol, V.; Nikkels, A.; Kruse, V.; Sales, F.; Stas, M.; Van Laethem, A.; Garmyn, M. title: Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic date: 2020-08-12 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16772 sha: doc_id: 304946 cord_uid: fs02dxg5 nan As a result of the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and government lockdown measures, healthcare systems were challenged worldwide.


id: cord-310841-scg0h40b
author: Atzori, L.
date: 2020-04-15
extension: .txt
mime: text/plain
words: 975
sentence: 53
flesch: 45
cache: cache/cord-310841-scg0h40b.txt
txt: txt/cord-310841-scg0h40b.txt
title:
  Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy)

summary:
  As isolation is the main weapon to control the spread, 4 and on March 9, 2020 a Decree of the President of the Council of Ministers ordered the suspension of all outpatients' services, including clinics for psoriasis patients. As dermatologists are specialists not directly involved in the management of critical patients, the supply of specific protective equipment against bio-hazards, as well as of environmental sanitizers, was very limited, and the massive consumption from critical care wards depleted all stocks.


id: cord-300995-tqz2bkdo
author: Tagliaferri, Luca
title: Skin cancer triage and management during COVID‐19 pandemic
date: 2020-04-25
extension: .txt
mime: text/plain
words: 1413
sentence: 46
flesch: 36
cache: cache/cord-300995-tqz2bkdo.txt
txt: txt/cord-300995-tqz2bkdo.txt
summary:
  We suggest practical recommendations about follow-up and treatment of skin cancer patients during the COVID-19 pandemic. A useful approach, as already suggested by other authors, is to identify the different classes of priorities, both for the patients and for health professionals [5, 6] .Only a few national and international societies have released specific recommendations for skin cancer patients [7] .


id: cord-311523-erntrh3p
author: Gisondi, P
title: Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice
date: 2020-04-22
extension: .txt
mime: text/plain
words: 2760
sentence: 118
flesch: 38
cache: cache/cord-311523-erntrh3p.txt
txt: txt/cord-311523-erntrh3p.txt
summary:
  In the areas of Italy severely affected by the coronavirus outbreak, extra beds have been created in Internal Medicine wards for COVID-19 patients; dermatologists, along with doctors from other medical subspecialties, have therefore been asked to provide assistance to COVID-19 patients in these departments due to the shortage of doctors. Shortage of medical masks for health workers due to panic shopping from the population may jeopardize the safety of physicians dealing with COVID-19 patients.


id: cord-277110-e27lm7rr
author: Iria, Neri
date: 2020-06-13
extension: .txt
mime: text/plain
words: 2907
sentence: 136
flesch: 47
cache: cache/cord-277110-e27lm7rr.txt
txt: txt/cord-277110-e27lm7rr.txt
title:
  Major cluster of pediatric “ true ” primary chilblains during the COVID‐19 pandemic: a consequence of lifestyle changes due to lockdown

summary:
  We were not able to test other patients due to the difficulties to access the hospital. The observation of other cases, with a careful clinical examination and an accurate history will provide further diagnostic clues and will be necessary to verify our hypothesis.


id: cord-290146-7fz9bj0b
author: Ring, J.
title: COVID‐19 and its implications for Dermatology and Venereology
date: 2020-05-22
extension: .txt
mime: text/plain
words: 708
sentence: 26
flesch: 38
cache: cache/cord-290146-7fz9bj0b.txt
txt: txt/cord-290146-7fz9bj0b.txt
summary:
  The question as to whether skin symptoms belong to the disease symptomatology is not often communicated, but even when they are reported, about 10 % of skin manifestations are described rather unspecifically as 'rash' (Recalcati, in this issue). The question as to whether and which of our patients with skin disease are at risk for developing severe COVID-19 symptoms touches our daily clinical practice and treatment, for example the use of immunosuppressants, topical or systemic drugs such as cyclosporine, methotrexate or the new biologics.


id: cord-345514-71qgingu
author: Najafzadeh, Mojgan
title: Urticaria (angioedema) and COVID‐ 19 infection
date: 2020-06-11
extension: .txt
mime: text/plain
words: 932
sentence: 46
flesch: 48
cache: cache/cord-345514-71qgingu.txt
txt: txt/cord-345514-71qgingu.txt
summary:
  It has been reported that in addition to the conventional respiratory symptoms, patients also display skin manifestations such as Urticaria and angioedema.(3) 1 2 It has been reported that in addition to the conventional respiratory symptoms, patients also display skin manifestations such as Urticaria and angioedema.


id: cord-322069-ys9s7l6e
author: Gaspari, Valeria
date: 2020-06-03
extension: .txt
mime: text/plain
words: 833
sentence: 46
flesch: 51
cache: cache/cord-322069-ys9s7l6e.txt
txt: txt/cord-322069-ys9s7l6e.txt
title:
  COVID‐19: how it can look on the skin. Clinical and pathological features in twenty COVID‐19 patients observed in Bologna, northeastern Italy

summary:
  The clinical patterns of the rashes described in COVID-19 patients till now include urticaria, acral ischemia, morbilliform, livedo reticularis, vesicular, and petechial [5;7-9] . Coronavirus disease 2019 (covid-19) Situation Report -29 Clinical Characteristics of Coronavirus Disease 2019 in China Ministero della salute.


id: cord-300546-s29ycc8i
author: Balestri, R.
title: Occurrence of SARS‐CoV‐2 during mycophenolate mofetil treatment for pemphigus
date: 2020-05-02
extension: .txt
mime: text/plain
words: 805
sentence: 29
flesch: 43
cache: cache/cord-300546-s29ycc8i.txt
txt: txt/cord-300546-s29ycc8i.txt
summary:
  The authors conclude that it is crucial to learn of more cases of ABD patients under immunosuppressive treatment who have developed COVID‐19, in order to better quantify the risk of infection under immunosuppressive therapy. The authors conclude that it is crucial to learn of more cases of ABD patients under immunosuppressive treatment who have developed COVID-19, in order to better quantify the risk of infection under immunosuppressive therapy.


id: cord-340842-s00465sy
author: Cabrera‐Hernández, R.
title: SARS‐CoV‐2, skin lesions and the need of a multidisciplinary approach
date: 2020-06-13
extension: .txt
mime: text/plain
words: 852
sentence: 33
flesch: 41
cache: cache/cord-340842-s00465sy.txt
txt: txt/cord-340842-s00465sy.txt
summary:
  Even in lesions with apparent vascular involvement, which have been associated with alterations in coagulation,3-5 the analitycal parameters did not differ from those with other types of skin lesions. key: cord-340842-s00465sy authors: Cabrera‐Hernández, R.; Solano‐Solares, E.; Chica‐Guzmán, V.; Fernández‐Guarino, M.; Fernández‐Nieto, D.; Ortega‐Quijano, D.; de‐Andrés‐Martín, A.; Moreno, C.; Carretero‐Barrio, I.; García‐Abellás, P.; González‐de‐Olano, D.; de‐la‐Hoz‐Caballer, B. title: SARS‐CoV‐2, skin lesions and the need of a multidisciplinary approach date: 2020-06-13 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16745 sha: doc_id: 340842 cord_uid: s00465sy COVID‐19 is a disease caused by severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus (SARS‐CoV‐2).


id: cord-267748-uzt8a5nx
author: Shiohara, Tetsuo
date: 2020-09-24
extension: .txt
mime: text/plain
words: 926
sentence: 32
flesch: 27
cache: cache/cord-267748-uzt8a5nx.txt
txt: txt/cord-267748-uzt8a5nx.txt
title:
  Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19

summary:
  key: cord-267748-uzt8a5nx authors: Shiohara, Tetsuo; Mizukawa, Yoshiko title: Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date: 2020-09-24 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16959 sha: doc_id: 267748 cord_uid: uzt8a5nx We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug‐induced hypersensitivity syndrome (DiHS), in a COVID‐19 patient:(1) the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient: 1 the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine.


id: cord-346763-xdfl659q
author: Herman, A.
title: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19
date: 2020-08-13
extension: .txt
mime: text/plain
words: 1322
sentence: 43
flesch: 38
cache: cache/cord-346763-xdfl659q.txt
txt: txt/cord-346763-xdfl659q.txt
summary:
  key: cord-346763-xdfl659q authors: Herman, A.; Matthews, M.; Mairlot, M.; Nobile, L.; Fameree, L.; Jacquet, L.‐M.; Baeck, M. title: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19 date: 2020-08-13 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16838 sha: doc_id: 346763 cord_uid: xdfl659q Skin rashes associated with COVID-19 include eruptions induced by drugs prescribed for management of this infection. We report a case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with COVID-19.


